Part of oregon university system
Clinical Trials
37
5 active
Approvals
0
Total approvals
Agencies
0
Regulatory bodies
Founded
1868
Active, not recruiting
5
13.5%
Completed
27
73.0%
Recruiting
3
8.1%
Terminated
2
5.4%
No approval data available
- Oregon State University researchers have developed gold nanorods coated with iron-cobalt shells that enable complete melanoma tumor ablation using laser power below skin safety thresholds. - The nanoparticles utilize resonance energy transfer to heat up efficiently at 0.25 W/cm², well below the 0.33 W/cm² safety limit, achieving complete tumor destruction in aggressive melanoma mouse models. - The theranostic platform combines treatment and diagnostic capabilities, functioning as both a photothermal therapy agent and fluorescence imaging guide for precise tumor targeting. - This breakthrough addresses the persistent safety limitations of conventional photothermal therapy, offering a minimally invasive alternative to surgical procedures requiring extensive tissue removal.
- Early research suggests CBD may help curb SARS-CoV-2 replication in infected cells, warranting further investigation through rigorous clinical trials. - Studies indicate CBD acts post-infection, blocking virus replication, while THC and other cannabinoids do not show the same antiviral effects. - Researchers emphasize that current evidence does not support self-medication with CBD and highlight the importance of vaccines and antibody drugs. - Clinical trials are underway to assess CBD's efficacy in treating COVID-19, with challenges in enrolling patients due to milder Omicron cases.
